1. Home
  2. BTQ vs CDNA Comparison

BTQ vs CDNA Comparison

Compare BTQ & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTQ

BTQ Technologies Corp.

N/A

Current Price

$5.49

Market Cap

929.8M

Sector

N/A

ML Signal

N/A

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.15

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTQ
CDNA
Founded
1983
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
929.8M
1.0B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BTQ
CDNA
Price
$5.49
$19.15
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$10.00
$26.67
AVG Volume (30 Days)
3.1M
768.6K
Earning Date
03-25-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
$405,988.00
$357,998,000.00
Revenue This Year
$100.70
$14.11
Revenue Next Year
$669.96
$11.75
P/E Ratio
N/A
$16.03
Revenue Growth
35.72
14.46
52 Week Low
$0.95
$10.96
52 Week High
$16.00
$25.95

Technical Indicators

Market Signals
Indicator
BTQ
CDNA
Relative Strength Index (RSI) N/A 54.88
Support Level N/A $19.01
Resistance Level N/A $20.61
Average True Range (ATR) 0.00 0.80
MACD 0.00 -0.15
Stochastic Oscillator 0.00 25.75

Price Performance

Historical Comparison
BTQ
CDNA

About BTQ BTQ Technologies Corp.

BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. Its products include PQScale, Keelung, Kenting, and Qbyte. PQScale is a novel scaling technique for post-quantum cryptographic primitives. Keelung is a zero-knowledge toolkit for fast, private, and secure applications. Kenting provides acceleration for NIST-compliant post-quantum cryptography, post-quantum zk-SNARKs, and eco-friendly mining hardware, and Qbyte is a quantum risk calculator. Geographically, the company derives maximum revenue from Canada, and also has a presence in Taiwan, and Australia.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: